How a worm protein similar to human Neuregulin is made and released

Exploring the function and shedding of a potential C. elegans Neuregulin

NIH-funded research California State University Northridge · NIH-11330334

Researchers are looking at how a protein in nematode worms that resembles human Neuregulin is produced and released, to better understand cell signaling tied to conditions like cancer and sleep changes.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionCalifornia State University Northridge NIH-funded
Lab location1 site (Northridge, United States)
Project IDNIH-11330334 on NIH RePORTER

What this research studies

This project uses the tiny roundworm C. elegans as a model to find and study a Neuregulin-like protein and the way its active piece is cut loose from the cell surface. Scientists will use genetic tools, molecular biology, and biochemical tests to track the protein, identify enzymes that release it, and see how this signaling affects stress-triggered sleep-like behavior. Some experiments may use other simple animals (like zebrafish) and lab assays to check whether the mechanism is conserved across species. The work focuses on basic lab research rather than treating people directly.

Who could benefit from this research

Good fit: People affected by conditions tied to EGF/ErbB signaling (for example some cancers or disorders with altered sleep regulation) may find the findings relevant to future therapies, though this project does not enroll patients.

Not a fit: Patients looking for immediate treatment options or clinical trials will not benefit directly because this is laboratory research in model organisms rather than a human study.

Why it matters

Potential benefit: If successful, the work could clarify how EGF-family signals are regulated and point toward new ideas for treating disorders linked to EGF signaling, such as certain cancers or sleep-regulation problems.

How similar studies have performed: Previous studies across worms, flies, fish, and mammals have shown EGF-family signals influence development and sleep, but identifying a new Neuregulin-like ligand and its stress-triggered release mechanism is relatively novel.

Where this research is happening

Northridge, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.